Stay updated on APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F07pjnayN4G-7dU3VZL-eOHgIK58.uncropped.jpg&w=3840&q=75)
Latest updates to the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0 and now includes 7 locations, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the content on the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has been updated to 'Drug Information available for: Paclitaxel, Gemcitabine, Gemcitabine hydrochloride, Nivolumab, FDA Drug and Device Resources'. This change reflects an update in the drug information available on the webpage.SummaryDifference32%
Stay in the know with updates to APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.